Phibro Animal Health Corp
PAHC38.460USD
+6.260+19.44%
交易中 （美东）报价延迟15分钟
1.56B总市值
49.04市盈率 TTM
关于 Phibro Animal Health Corp 公司
Phibro Animal Health Corporation 是一家全球多元化动物保健和矿物质营养公司。该公司开发、生产和销售一系列食品和伴侣动物产品，包括家禽、猪、肉牛和奶牛、水产养殖和狗。该公司向 80 多个国家的大约 4,200 名客户销售约 750 条产品线。该公司有三个部门：动物保健、矿物质营养和性能产品。其动物保健部门开发、生产和销售约 280 条产品线，包括抗菌药、抗球虫药和相关产品；营养特种产品；和疫苗。矿物质营养部门包括锌、锰、铜、铁和其他化合物等微量矿物质的配方和浓度，重点关注北美客户。性能产品部门生产和销售用于个人护理、工业化学品和化学催化剂行业的特种成分。
公司简介
公司代码PAHC
公司名称Phibro Animal Health Corp
上市日期Apr 11, 2014
CEOMr. Jack C. Bendheim
员工数量1940
证券类型Ordinary Share
年结日Apr 11
公司地址Glenpointe Centre East, 3Rd Floor
城市TEANECK
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编07666
电话12013297300
网址https://www.pahc.com/
公司代码PAHC
上市日期Apr 11, 2014
CEOMr. Jack C. Bendheim
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
35.18K
+17.28%
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
34.84K
+16.15%
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
30.00K
+20.00%
Mr. Daniel M. Bendheim
Mr. Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Executive Vice President - Corporate Strategy, Director
3.96K
--
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
3.27K
--
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
1.79K
--
Ms. Carol A. Wrenn
Ms. Carol A. Wrenn
Independent Director
Independent Director
1.00K
--
Mr. Sam Gejdenson
Mr. Sam Gejdenson
Independent Director
Independent Director
--
--
Ms. Judith A. Weinstein
Ms. Judith A. Weinstein
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
--
--
Ms. Joyce J. Lee
Ms. Joyce J. Lee
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
35.18K
+17.28%
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
34.84K
+16.15%
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
30.00K
+20.00%
Mr. Daniel M. Bendheim
Mr. Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Executive Vice President - Corporate Strategy, Director
3.96K
--
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
3.27K
--
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
1.79K
--
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
MFAs and Other
181.65M
52.22%
Nutritional specialties
43.35M
12.46%
Vaccines
33.38M
9.60%
地区USD
名称
营收
占比
United States
209.94M
60.36%
Latin America and Canada
70.75M
20.34%
Europe & Middle East & Africa
38.91M
11.19%
Asia Pacific
28.22M
8.11%
业务
地区
业务USD
名称
营收
占比
MFAs and Other
181.65M
52.22%
Nutritional specialties
43.35M
12.46%
Vaccines
33.38M
9.60%
股东统计
更新时间: 8月23日 周六
更新时间: 8月23日 周六
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
14.45%
The Vanguard Group, Inc.
7.58%
State Street Global Advisors (US)
4.46%
Acadian Asset Management LLC
3.56%
ExodusPoint Capital Management, LP
3.34%
其他
66.61%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
14.45%
The Vanguard Group, Inc.
7.58%
State Street Global Advisors (US)
4.46%
Acadian Asset Management LLC
3.56%
ExodusPoint Capital Management, LP
3.34%
其他
66.61%
股东类型
持股股东
占比
Investment Advisor
56.03%
Investment Advisor/Hedge Fund
28.92%
Hedge Fund
15.11%
Research Firm
2.79%
Pension Fund
1.76%
Individual Investor
0.65%
Bank and Trust
0.39%
Corporation
0.29%
Sovereign Wealth Fund
0.05%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
377
20.85M
102.34%
-3.11M
2025Q1
383
21.67M
106.42%
-2.98M
2024Q4
360
21.95M
107.94%
-1.91M
2024Q3
348
21.46M
105.50%
-2.61M
2024Q2
357
21.32M
104.83%
-3.05M
2024Q1
350
21.49M
105.66%
-2.40M
2023Q4
349
21.13M
103.91%
-1.66M
2023Q3
339
20.38M
100.19%
-2.22M
2023Q2
341
20.61M
101.32%
-2.12M
2023Q1
350
20.77M
102.13%
-2.00M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
3.10M
15.24%
-58.95K
-1.86%
Mar 31, 2025
The Vanguard Group, Inc.
1.52M
7.45%
+6.78K
+0.45%
Mar 31, 2025
State Street Global Advisors (US)
920.19K
4.52%
-26.64K
-2.81%
Mar 31, 2025
Acadian Asset Management LLC
782.94K
3.84%
+4.14K
+0.53%
Mar 31, 2025
Renaissance Technologies LLC
705.30K
3.46%
+147.50K
+26.44%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
643.91K
3.16%
-73.20K
-10.21%
Mar 31, 2025
Geode Capital Management, L.L.C.
547.09K
2.69%
+31.11K
+6.03%
Mar 31, 2025
Castleknight Management LP
417.75K
2.05%
+28.31K
+7.27%
Mar 31, 2025
Nuveen LLC
481.80K
2.37%
-105.20K
-17.92%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月6日 周三
更新时间: 8月6日 周三
机构名称
占比
Brandes US Small-Mid Cap Value ETF
1.22%
SPDR S&P Pharmaceuticals ETF
0.86%
Lattice Hartford Multifactor Small Cap ETF
0.71%
Invesco S&P SmallCap 600 Pure Growth ETF
0.7%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
0.53%
Invesco NASDAQ Future Gen 200 ETF
0.47%
Invesco S&P SmallCap Health Care ETF
0.36%
Royce Quant Small-Cap Quality Value ETF
0.28%
Zacks Small/Mid Cap ETF
0.27%
Harbor Human Capital Factor US Small Cap ETF
0.21%
查看更多
Brandes US Small-Mid Cap Value ETF
占比1.22%
SPDR S&P Pharmaceuticals ETF
占比0.86%
Lattice Hartford Multifactor Small Cap ETF
占比0.71%
Invesco S&P SmallCap 600 Pure Growth ETF
占比0.7%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
占比0.53%
Invesco NASDAQ Future Gen 200 ETF
占比0.47%
Invesco S&P SmallCap Health Care ETF
占比0.36%
Royce Quant Small-Cap Quality Value ETF
占比0.28%
Zacks Small/Mid Cap ETF
占比0.27%
Harbor Human Capital Factor US Small Cap ETF
占比0.21%
分红派息
近5年累计派现
97.17M
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Feb 04, 2025
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 26, 2025 going ex on Mar 05, 2025
Mar 05, 2025
Mar 26, 2025
Mar 05, 2025
Nov 05, 2024
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 18, 2024 going ex on Nov 27, 2024
Nov 27, 2024
Dec 18, 2024
Nov 27, 2024
Jul 30, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 25, 2024 going ex on Sep 04, 2024
Sep 04, 2024
Sep 25, 2024
Sep 04, 2024
May 07, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 26, 2024 going ex on Jun 05, 2024
Jun 05, 2024
Jun 26, 2024
Jun 05, 2024
Feb 06, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 27, 2024 going ex on Mar 05, 2024
Mar 06, 2024
Mar 27, 2024
Mar 05, 2024
Nov 06, 2023
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 20, 2023 going ex on Nov 28, 2023
Nov 29, 2023
Dec 20, 2023
Nov 28, 2023
Jul 25, 2023
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 27, 2023 going ex on Sep 05, 2023
Sep 06, 2023
Sep 27, 2023
Sep 05, 2023
May 01, 2023
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 28, 2023 going ex on Jun 06, 2023
Jun 07, 2023
Jun 28, 2023
Jun 06, 2023
Feb 06, 2023
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 22, 2023 going ex on Feb 28, 2023
Mar 01, 2023
Mar 22, 2023
Feb 28, 2023
Nov 07, 2022
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 21, 2022 going ex on Nov 29, 2022
Nov 30, 2022
Dec 21, 2022
Nov 29, 2022
查看更多
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
